Litigation Details for BioDelivery Sciences International, Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)
✉ Email this page to a colleague
BioDelivery Sciences International, Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)
Docket | ⤷ Sign Up | Date Filed | 2017-02-02 |
Court | District Court, D. Delaware | Date Terminated | 2018-02-06 |
Cause | 35:271 Patent Infringement | Assigned To | Gregory Moneta Sleet |
Jury Demand | None | Referred To | |
Parties | BIODELIVERY SCIENCES INTERNATIONAL, INC. | ||
Patents | 7,579,019; 8,147,866 | ||
Attorneys | Karen Elizabeth Keller | ||
Firms | Morris, Nichols, Arsht & Tunnell | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in BioDelivery Sciences International, Inc. v. Teva Pharmaceuticals USA, Inc.
Details for BioDelivery Sciences International, Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2017-02-02 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,579,019 B2; 8,147,866 B2. (…2017 7 February 2018 1:17-cv-00118 830 Patent None District Court, D. Delaware | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |